These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2687555)

  • 21. The role of serotonin in cardiovascular disease.
    Frohlich ED
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S1-2. PubMed ID: 2446053
    [No Abstract]   [Full Text] [Related]  

  • 22. Central 5-hydroxytryptamine (5-HT) receptors in blood pressure regulation.
    Dabiré H
    Therapie; 1991; 46(6):421-9. PubMed ID: 1819150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs.
    van Zwieten PA; Blauw GJ; van Brummelen P
    Clin Physiol Biochem; 1990; 8 Suppl 3():1-18. PubMed ID: 2132170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.
    Liechti ME; Saur MR; Gamma A; Hell D; Vollenweider FX
    Neuropsychopharmacology; 2000 Oct; 23(4):396-404. PubMed ID: 10989266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension.
    Hosie J; Stott DJ; Robertson JI; Ball SG
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S86-8. PubMed ID: 2446081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
    Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of ketanserin and metoprolol in the treatment of essential hypertension.
    Sheps SG; Schirger A; Zachariah PK; Fisher LD; Spiekerman RE; Araas FJ; Collins JB; Agerter DC
    Arch Intern Med; 1987 Feb; 147(2):291-6. PubMed ID: 3545116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of ketanserin on blood pressure and platelets during cardiopulmonary bypass.
    Lichtenthal PR; Wade LD; Rossi EC
    Anesth Analg; 1987 Nov; 66(11):1151-4. PubMed ID: 3662060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of ketanserin in the treatment of the essential arterial hypertension associated with ischemic heart disease.
    Podoleanu D; Cotoi S
    Rom J Intern Med; 1996; 34(1-2):49-54. PubMed ID: 8908630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketanserin, hypertension, and chronic alcoholism: double-blind study in forty patients.
    de Lorenzo A; Ceccanti M; Assogna G; Romeo M; Cavaleri G; Attilia ML
    Int J Clin Pharmacol Res; 1988; 8(5):321-5. PubMed ID: 3068159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The antihypertensive efficacy of ketanserin in the elderly evaluated by ambulatory blood pressure measurement.
    McCormack PM; Cox JP; Marron J; Mee F; Atkins N; O'Brien E; O'Malley K
    J Hum Hypertens; 1990 Oct; 4(5):565-70. PubMed ID: 2283647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin and preactivated platelets in essential hypertension.
    Bühler FR; Amstein R; Fetkovska N
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S32-4. PubMed ID: 2446066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure patterns in pregnant patients on oral ketanserin.
    Steyn DW; Odendaal HJ
    Cardiovasc J S Afr; 2001; 12(2):82-7. PubMed ID: 11447496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Role of ketanserin in the treatment of arterial hypertension].
    Cricco L
    Clin Ter; 1990 Aug 15-31; 134(3-4):199-203. PubMed ID: 2147621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Use of ketanserin in anesthesia. A selective S2 serotonin receptor antagonist].
    Nielsen LH; Knudsen F; Olesen AS
    Ugeskr Laeger; 1990 Jun; 152(23):1653-5. PubMed ID: 2194327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
    Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
    Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of a serotonin S2 receptor antagonist on portal hypertension due to cirrhosis. Preliminary results of a heart and liver hemodynamic study].
    Deflandre J; Pirotte J; Etienne M; Carlier J
    Ann Gastroenterol Hepatol (Paris); 1988; 24(3):103-5. PubMed ID: 3400992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
    Bühler FR; Amstein R
    Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of acute and chronic effects of ketanserin in the treatment of hypertension and hypothesis on a new mechanism of action].
    Sechi LA
    Ann Ital Med Int; 1990; 5(4 Pt 2):433-50. PubMed ID: 2102130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effectiveness of ketanserin in the treatment of light-to-moderate arterial hypertension].
    Poletti L; Fogari R; Bressan MA; Poggio M; Daglio M; Ripamonti L; Vlacos D; Azzaretti G
    Clin Ter; 1993 Sep; 143(3):213-7. PubMed ID: 8222552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.